Paclitaxel-eluting stent versus conventional stent in STE-myocardial infarction; angiographic long-term evaluation;Long-term angiographic follow-up after primary PCI for acute myocardial infarction; paclitaxel-eluting stent versus bare metal stent, as performed in the PASSION trial
A single blinded, randomized, dual center study

Long-term angiographic results after elective PCI with the use of BMS have
shown sustained efficacy several years after placement. This information
concerning stent-patency is currently lacking for stents placed during primary
PCI.
DES stents reduce the rate of both short-term and long-term in-stent restenosis
after elective PCI, compared to bare-metal stents. At present time, only
limited clinical data are available about the long-term implications of these
stents.

Angiographic follow-up of DES in large patient groups late after primary PCI
is currently unavailable. By extending the PASSION protocol, we have the
opportunity to have the first angiographic analysis two to four years after
primary PCI, both after the placement of BMS as well as DES, in two
pre-specified groups with well matching clinical characteristics.

The original PASSION clinical study is a prospective, randomized, dual center,
single blinded study. Patients were treated randomly with Paclitaxel-eluting
stent(s) or a bare metal stent. These patients will be contacted to give
permission for a one-day admission to one of the two study centers to undergo
bicycle ergometry and coronary angiography, and intravascular ultrasound will
be performed in a subgroup of patients.

Admission on a one-day basis with diagnostic tests (bicycle ergometry, coronary
angiography).
Svere cardiovascular complications related to coronary angiography normally
occurs in apprximately 0.1%.